Endo International PLC
NASDAQ:ENDP
Endo International PLC
Net Income (Common)
Endo International PLC
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Endo International PLC
NASDAQ:ENDP
|
Net Income (Common)
-$2.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Perrigo Company PLC
NYSE:PRGO
|
Net Income (Common)
-$12.7m
|
CAGR 3-Years
57%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Net Income (Common)
$330.7m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
15%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Net Income (Common)
-$160.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-14%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Net Income (Common)
-$35.6m
|
CAGR 3-Years
-329%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Net Income (Common)
€1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-34%
|
See Also
What is Endo International PLC's Net Income (Common)?
Net Income (Common)
-2.9B
USD
Based on the financial report for Dec 31, 2022, Endo International PLC's Net Income (Common) amounts to -2.9B USD.
What is Endo International PLC's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-377%
Over the last year, the Net Income (Common) growth was -377%.